2[4]Vgontzas A N,Papanicolaou D A,Bixler E O,et al.Circadian interleukin-6 secretion and quantity and depth of sleep.J Clin Endocrinol Metab,1999,84:2603-2607.
3[5]Shearer W T,Reuben J M,Mullington J M,et al.Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.J Allergy Clin Immunol,2001,107:165-170.
4[6]Shamsuzzaman A S,Winnicki M,Lanfranchi P,et al.Elevated C-reactive protein in patients with obstructive sleep apnea.Circulation,2002,105:2462-2464.
5[7]Rangemark C,Hedner J A,Carlson J T,et al.Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients.Sleep,1995,18:188-194.
6[1]Ridker P M.High-sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.Circulation,2001,103:1813-1818.
7[2]Albert M A,Danielson E,Rifai N,et al.Effect of statin therapy on C-reactive protein levels:the pravastatin inflammation/CRP evaluation(PRINCE) :a randomized trial and cohort study.JAMA,2001,286:64-70.
8Conway DS,Pearce LA,Chin BS,et al.Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors[J ].Circulation,2002,106(15): 1962-1967.
9BlannAD,McCollum CN,LipGY.Relationship between plasma markers of endothelial cell integrity and the Framinghan cardiovascular disease risk-factor score in apparently healthy individuals[J].Blood Coagul Fibrinolysis,2003,14(3) :315-317.
10George T,Niemeyer A,Rogge P,et al.Secretion pores in human endothelial cells during acute hypoxia[J ].J Membr Biol,2002,187(3):203-211.
